Melatonin attenuates the changes in polyamine levels induced by systemic kainate administration in rat brains

Journal of the Neurological Sciences

Volumn 178, Issue 2, 2000, Pages 124-131

  Lee, Young Kuk ^a   Lee, Seong Ryong ^b   Kim, Choong Young ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

Cortex; Excitotoxicity; Hippocampus; Kainate; Melatonin; Neuroprotectio n; Polyamines

Indexed keywords

KAINIC ACID; MELATONIN; PUTRESCINE; SPERMIDINE; SPERMINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NERVE CELL EXCITABILITY; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONVULSIONS; HIPPOCAMPUS; KAINIC ACID; MALE; MELATONIN; POLYAMINES; PUTRESCINE; RATS; RATS, SPRAGUE-DAWLEY; SPERMIDINE; SPERMINE;

EID: 0034665463     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00393-2     Document Type: Article

References (47)

1. Tabor C.W., Tabor H. Polyamines. Annu Rev Biochem. 53:1984;749-790.
2. Pegg A.E. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J. 234:1986;249-262.
3. Williams K., Romano C., Dichter M.A., Molinoff P.B. Modulation of the NMDA receptor by polyamines. Life Sci. 48:1991;469-498.
4. Koenig H., Goldsteine A.D., Lu C.Y. Polyamines regulate calcium fluxes in a rapid plasma membrane response. Nature. 305:1983;530-534.
5. ++ fluxes and neurotransmitter release in potassium-depolarized synaptosomes. Biochem Biophys Res Commun. 133:1985;563-573.
6. Bondy S.C., Walker C.H. Polyamines contribute to calcium-stimulated release of aspartate from brain particulate fractions. Brain Res. 371:1986;96-100.
7. Benveniste H., Drejer J., Schousbe A., Deimer N.H. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 43:1984;1369-1374.
8. Choi D.W., Rothman S.M. Role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 13:1990;171-182.
9. Olney J.W., Rhee V., Ho O.L. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res. 77:1974;507-512.
10. Young A.B., Fagg G.E. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol Sci. 11:1990;126-133.
11. Ben-Ari Y. Limbic seizure and brain damage produced by kainate acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
12. Reed L.J., de Belleroche J. Induction of ornithine decarboxylase in cerebral cortex by excitotoxin lesion of nucleus basalis: association with postsynaptic responsiveness and N-methyl-D-aspartate receptor activation. J Neurochem. 55:1990;780-787.
13. Martinez E., de Vera N., Artigas F. Differential response of rat brain polyamines to convulsant agents. Life Sci. 48:1991;77-84.
14. Najm I., el-Skaf G., Massicotte G., Vanderklish P., Lynch G., Baudry M. Changes in polyamine levels and spectrin degradation following kainate-induced seizure activity: effect of difluoromethylornithine. Exp Neurol. 116:1992;345-354.
15. Conti A., Maestroni G.J.M. The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res. 19:1995;103-110.
16. Maestroni G.J.M., Conti A., Pierpaoli W. Role of the pineal gland in immunity: circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol. 13:1986;19-30.
17. Maestroni G.J.M., Conti A., Pierpaoli W. Role of the pineal gland in immunity: II circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Clin Exp Immunol. 68:1987;384-391.
18. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:1995;526-533.
19. Tan D.Z., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J. 1:1993;57-60.
20. Cagnoli C.M., Atabay C., Kharlamov E., Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res. 18:1995;222-226.
21. Guerrero J.M., Reiter R.J., Ortiz G.G., Pablos M.I., Sewerynek E., Chuang J.I. Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res. 23:1997;24-31.
22. Giusti P., Lipartiti M., Franceschini D., Schiavo N., Floreani M., Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10:1996;891-896.
23. Uz T., Giusti P., Franceschini D., Kharlamov A., Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience. 73:1996;631-636.
24. Manev H., Uz T., Kharlamov A., Cagnoli C.M., Franceschini D., Giusti P. In vivo protection against kainate-induced apoptosis by the pineal hormone melatonin: effect of exogenous melatonin and circadian rhythm. Restor Neurol Neurosci. 9:1996;251-256.
25. Kotler M., Rodriguez C., Sainz R.M., Antolin I., Menendez-Pelaez A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res. 24:1998;83-89.
26. Spragg B.P., Hutchings A.D. High-performance liquid chromatographic determination of putrescine, spermidine, and spermine after deprivation with 4-fluoro-3-nitroben-zotrifluoride. J Chromatogr. 258:1983;289-292.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 4th ed. 1998;Academic Press, San Diego.
28. Eke A., Conger K.A., Anderson M. Histological assessment of neurons in rat model of cerebral ischemia. Stroke. 21:1990;299-304.
29. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
30. Coyle J.T. Neurotoxic action of kainic acid. J Neurochem. 41:1983;1-11.
31. Pastuszko A., Wilson D.F., Erecinska F. Effects of kainic acid in rat synaptosomes: the involvement of calcium. J Neurochem. 43:1984;747-754.
32. Young A.M.J., Crowder J.M., Bradford H.F. Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J Neurochem. 50:1988;337-345.
33. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptors. Trends Neurosci. 10:1987;299-302.
34. Schwob J.E., Fuller T., Price J.L., Olney J.W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainate acid: a histologic study. Neuroscience. 5:1980;991-1014.
35. Trout J.J., Koenig H., Goldstone A.D., Lu C.Y. Blood-brain barrier breakdown by cold injury. Polyamine signals mediate acute stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries. Lab Invest. 55:1986;622-631.
36. 2+ mediate hyperosmolal opening of the blood-brain barrier: in vitro studies in isolated rat cerebral capillaries. J Neurochem. 52:1989;1135-1142.
37. 3H] MK-801 binding to the NMDA receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem. 51:1988;830-836.
38. 3H-MK-801 to the NMDA receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol. 36:1989;575-581.
39. Paschen W., Rohn G., Meese C.O., Djuricic B., Schmidt-Kastner R. Polyamine metabolism in reversible cerebral ischemia: effect of α-difluoromethylornithine. Brain Res. 453:1988;9-16.
40. Baskaya M.K., Rao A.M., Puckett L., Prasad M.R., Dempsey R.J. Effect of difluoromethylornithine treatment on regional ornithine decarboxylase activity and edema formation after experimental brain injury. J Neurotrauma. 13:1997;85-92.
41. Baskaya M.K., Rao A.M., Dogan A., Donaldson D., Gellin G., Dempsey R.J. Regional brain polyamine levels in permanent focal cerebral ischemia. Brain Res. 744:1997;302-308.
42. Hayashi Y., Hattori Y., Moriwaki A., Lu Y.F., Hori Y. Increases in brain polyamine concentrations in chemical kindling and single convulsion induced by pentylenetetrazol in rats. Neurosci Lett. 149:1992;63-66.
43. Kindy M.S., Hu Y., Dempsey R.J. Blockade of ornithine decarboxylase enzyme protects against ischemic brain damage. J Cereb Blood Flow Metab. 14:1994;1040-1045.
44. de Vera N., Artigas F., Serratosa J., Martinez E. Changes in polyamine levels in rat brain after systemic kainic acid administration: relationship to convulsant activity and brain damage. J Neurochem. 57:1991;1-8.
45. Reiter R., Tang L., Garcia J.J., Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:1997;2255-2271.
46. Skaper S.D., Ancona B., Facci L., Franceschini D., Giusti P. Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB J. 12:1998;725-731.
47. Tsirka S.E., Gualandris A., Amaral D.G., Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature (London). 377:1995;340-344.